HK1203198A1 - Substituted phenylimidazopyrazoles and use thereof - Google Patents

Substituted phenylimidazopyrazoles and use thereof

Info

Publication number
HK1203198A1
HK1203198A1 HK15103743.7A HK15103743A HK1203198A1 HK 1203198 A1 HK1203198 A1 HK 1203198A1 HK 15103743 A HK15103743 A HK 15103743A HK 1203198 A1 HK1203198 A1 HK 1203198A1
Authority
HK
Hong Kong
Prior art keywords
phenylimidazopyrazoles
substituted
substituted phenylimidazopyrazoles
Prior art date
Application number
HK15103743.7A
Other languages
English (en)
Chinese (zh)
Inventor
Frank Smeier
Mario Lobell
Sylvia Grnewald
Michael Hrter
Bernd Buchmann
Joachim Telser
Hannah Jrien
Melanie Heroult
Antje Kahnert
Klemens Lustig
Niels Lindner
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47594775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1203198(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HK1203198A1 publication Critical patent/HK1203198A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK15103743.7A 2012-01-25 2015-04-17 Substituted phenylimidazopyrazoles and use thereof HK1203198A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12152515 2012-01-25
PCT/EP2013/051106 WO2013110590A1 (de) 2012-01-25 2013-01-22 Substituierte phenylimidazopyrazole und ihre verwendung

Publications (1)

Publication Number Publication Date
HK1203198A1 true HK1203198A1 (en) 2015-10-23

Family

ID=47594775

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103743.7A HK1203198A1 (en) 2012-01-25 2015-04-17 Substituted phenylimidazopyrazoles and use thereof

Country Status (31)

Country Link
US (2) US20150005288A1 (xx)
EP (1) EP2807162B1 (xx)
JP (1) JP6101290B2 (xx)
KR (1) KR20140117582A (xx)
CN (1) CN104411707B (xx)
AP (1) AP2014007869A0 (xx)
AR (1) AR089788A1 (xx)
AU (1) AU2013211707A1 (xx)
BR (1) BR112014018450A8 (xx)
CA (1) CA2862163A1 (xx)
CL (1) CL2014001959A1 (xx)
CO (1) CO7101244A2 (xx)
CR (1) CR20140362A (xx)
CU (1) CU20140096A7 (xx)
DO (1) DOP2014000173A (xx)
EA (1) EA201491427A1 (xx)
EC (1) ECSP14010868A (xx)
ES (1) ES2639338T3 (xx)
GT (1) GT201400161A (xx)
HK (1) HK1203198A1 (xx)
IL (1) IL233652A0 (xx)
MA (1) MA35877B1 (xx)
MX (1) MX2014008893A (xx)
PE (1) PE20142421A1 (xx)
PH (1) PH12014501687A1 (xx)
SG (1) SG11201404118XA (xx)
TN (1) TN2014000320A1 (xx)
TW (1) TW201343649A (xx)
UY (1) UY34590A (xx)
WO (1) WO2013110590A1 (xx)
ZA (1) ZA201405392B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150005288A1 (en) * 2012-01-25 2015-01-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof
CA3172586A1 (en) 2013-07-31 2015-02-05 Avalyn Pharma Inc. Aerosol imatininb compounds and uses thereof
US20180368404A1 (en) 2014-11-06 2018-12-27 Basf Se 3-pyridyl heterobicyclic compound for controlling invertebrate pests
BR112018007034B1 (pt) * 2015-10-08 2022-10-11 Fmc Corporation Composto, composição, método para controlar uma praga de invertebrados e semente revestida
UY38366A (es) * 2018-09-13 2020-04-30 Syngenta Participations Ag Compuestos de azol-amida pesticidamente activos
CN109096195A (zh) * 2018-09-27 2018-12-28 上海雅本化学有限公司 一种艾曲波帕的制备方法
CN114555555B (zh) * 2019-10-16 2024-03-01 拜耳公司 制备1，1’-二硫烷二基双(4-氟-2-甲基-5-硝基苯)的方法
WO2021155320A1 (en) * 2020-01-29 2021-08-05 Foghorn Therapeutics Inc. Compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
UA80171C2 (en) * 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
US7419978B2 (en) * 2003-10-22 2008-09-02 Bristol-Myers Squibb Company Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
KR101061599B1 (ko) * 2008-12-05 2011-09-02 한국과학기술연구원 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
EP2443123B1 (en) * 2009-06-15 2017-04-05 Rigel Pharmaceuticals, Inc. Small molecule inhibitors of spleen tyrosine kinase (syk)
KR101116756B1 (ko) * 2009-10-27 2012-03-13 한국과학기술연구원 단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
US20150005288A1 (en) * 2012-01-25 2015-01-01 Bayer Pharma Aktiengesellschaft Substituted phenylimidazopyrazoles and use thereof

Also Published As

Publication number Publication date
WO2013110590A1 (de) 2013-08-01
AR089788A1 (es) 2014-09-17
MX2014008893A (es) 2014-08-26
KR20140117582A (ko) 2014-10-07
TN2014000320A1 (en) 2015-12-21
PE20142421A1 (es) 2015-01-11
CR20140362A (es) 2014-08-21
BR112014018450A2 (xx) 2017-06-20
US20130190290A1 (en) 2013-07-25
MA35877B1 (fr) 2014-12-01
EP2807162B1 (de) 2017-06-07
ZA201405392B (en) 2015-12-23
CO7101244A2 (es) 2014-10-31
UY34590A (es) 2013-09-02
US9394309B2 (en) 2016-07-19
AU2013211707A1 (en) 2014-08-07
CA2862163A1 (en) 2013-08-01
CN104411707A (zh) 2015-03-11
CU20140096A7 (es) 2015-02-26
BR112014018450A8 (pt) 2017-07-11
AP2014007869A0 (en) 2014-08-31
CN104411707B (zh) 2017-03-01
PH12014501687A1 (en) 2014-10-20
US20150005288A1 (en) 2015-01-01
GT201400161A (es) 2015-03-05
ECSP14010868A (es) 2015-12-31
JP2015504904A (ja) 2015-02-16
SG11201404118XA (en) 2014-10-30
CL2014001959A1 (es) 2014-11-07
ES2639338T3 (es) 2017-10-26
EP2807162A1 (de) 2014-12-03
IL233652A0 (en) 2014-08-31
TW201343649A (zh) 2013-11-01
JP6101290B2 (ja) 2017-03-22
DOP2014000173A (es) 2014-08-31
EA201491427A1 (ru) 2015-01-30

Similar Documents

Publication Publication Date Title
HK1203493A1 (en) Substituted azabicycles and use thereof
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
HK1199023A1 (en) Substituted benzothienylpyrrolotriazines and uses thereof
HK1200822A1 (en) Substituted dipyridylamines and uses thereof
IL237309A0 (en) Benzocyclooctyne compounds and uses thereof
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
HK1210949A1 (en) Combinations and uses thereof
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
HK1201270A1 (en) Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides -5---5--
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
PL2882708T3 (pl) Nowe związki i ich zastosowania
PL2895751T3 (pl) Śruba i jej zastosowanie
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
RS56379B1 (sr) Kompozicija za zaštitu i uravnotežavanje kože
GB201222541D0 (en) Kiddibidet and pottibidet
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder
GB201213726D0 (en) Novel compounds and their use
GB201215414D0 (en) Composition and use
GB201222342D0 (en) Compounds and uses thereof
GB201214749D0 (en) Compounds and their uses
GB201207075D0 (en) New compounds and uses
GB201206973D0 (en) New compounds and uses
GB201206055D0 (en) New compounds and uses
GB201206393D0 (en) Use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220126